Search

​Counterfeiting is seldom discussed in popular culture, but as a crime it is one of the most lucrative, eclipsing even the drug trade. In 2017, counterfeiting was responsible for almost $1 trillion in illegal sales. Incredibly, counterfeiting accelerated during the COVID-19 pandemic. That was caused...

Candice Kline, a partner in Saul Ewing's bankruptcy practice, will be a moderator at Succession Planning for a Small Business – Part 2, presented by the ISBA Business Advice and Financial Planning Section, on June 21, 2022. Succession Planning for a Small Business – Part 2 Presented by the ISBA...

PMG and Sentral Release Plans for Dual-Tower Multifamily Development in Brickell Saul Ewing attorneys Luis Flores and Sophia Rub represented the venture in closing the property acquisition. “This transaction speaks to the strength of the PMG-Sentral partnership in acquiring prime real estate in one...

Candice Kline, a partner in Saul Ewing's bankruptcy practice, will be a moderator at Succession Planning for a Small Business – Part 1, presented by the ISBA Business Advice and Financial Planning Section, on June 17, 2022. Succession Planning for a Small Business – Part 1 Presented by the ISBA...

This week, the stock market officially turned bear for the first time since March 2020, raising once again the possibility of a brewing recession. By Ashley Fahey – Editor, The National Observer: Real Estate Edition

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...